Lisdexamphetamine as a novel therapy for hyperphagia in Prader-Willi syndrome
J Paediatr Child Health
.
2023 Mar;59(3):570-572.
doi: 10.1111/jpc.16351.
Epub 2023 Feb 7.
Authors
John Preddy
1
,
Sarah Smith-Wade
2
,
Kerryn Houghton
3
Affiliations
1
General Paediatrics, Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia.
2
General Paediatrics, Sydney Children's Hospital, Sydney, New South Wales, Australia.
3
Newborn Care, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
PMID:
36749028
DOI:
10.1111/jpc.16351
No abstract available
Publication types
Case Reports
MeSH terms
Humans
Hyperphagia / drug therapy
Lisdexamfetamine Dimesylate
Prader-Willi Syndrome* / drug therapy
Substances
Lisdexamfetamine Dimesylate